Sentiment Trading

Recce Pharmaceuticals Ltd is a pre-clinical-stage company developing synthetic antibiotics to combat antibiotic-resistant bacteria, a major threat to global health, with a focus on serving customers in Australia.

Recce Pharmaceuticals Ltd is a pre-clinical-stage company developing synthetic antibiotics to combat superbugs, but its financial health is uncertain, with a negative P/E ratio and a high-risk investment opportunity.